Kosnopfel et al. showed that YB-1 triggers tumorigenicity and metastatic potential of melanoma cells by promoting epithelial-to-mesenchymal transition (EMT)-like processes (Kosnopfel et al., 2018). This evidence concerns the gene YBX1 and melanoma.